Liven Pharmaceuticals Limited (PSX:LIVEN)
84.68
-0.33 (-0.39%)
At close: Apr 17, 2025
Liven Pharmaceuticals Balance Sheet
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Cash & Equivalents | 14.81 | 0.04 | 0.03 | 0.03 | 0.05 | 0.06 | Upgrade
|
Cash & Short-Term Investments | 14.81 | 0.04 | 0.03 | 0.03 | 0.05 | 0.06 | Upgrade
|
Cash Growth | 198114.36% | 40.83% | 0.20% | -44.73% | -12.81% | 81.53% | Upgrade
|
Other Current Assets | 10.19 | - | - | - | 0.4 | - | Upgrade
|
Total Current Assets | 285.39 | 0.04 | 0.03 | 0.03 | 0.45 | 0.06 | Upgrade
|
Property, Plant & Equipment | 648.77 | 119.66 | 131.45 | 144.55 | 159.1 | 174.37 | Upgrade
|
Other Long-Term Assets | 0.77 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
Total Assets | 972.63 | 119.72 | 131.5 | 144.6 | 159.58 | 174.45 | Upgrade
|
Accounts Payable | 19.07 | - | - | 0 | 0.07 | 4.23 | Upgrade
|
Accrued Expenses | - | 1.9 | 0.78 | 0.92 | 0.55 | 0.68 | Upgrade
|
Short-Term Debt | 25.06 | 238.51 | 237.62 | 235.35 | 233.11 | 226.33 | Upgrade
|
Total Current Liabilities | 66.62 | 240.41 | 238.4 | 236.27 | 233.74 | 231.24 | Upgrade
|
Long-Term Deferred Tax Liabilities | 1.72 | 13.11 | 15.72 | 18.62 | 21.84 | 25.15 | Upgrade
|
Total Liabilities | 68.34 | 253.51 | 254.12 | 254.89 | 255.58 | 256.39 | Upgrade
|
Common Stock | 930.4 | 121.24 | 121.24 | 121.24 | 121.24 | 121.24 | Upgrade
|
Retained Earnings | -26.12 | -293.09 | -288.3 | -283.07 | -276.67 | -270.73 | Upgrade
|
Comprehensive Income & Other | - | 38.06 | 44.44 | 51.54 | 59.43 | 67.55 | Upgrade
|
Shareholders' Equity | 904.28 | -133.8 | -122.62 | -110.29 | -96 | -81.95 | Upgrade
|
Total Liabilities & Equity | 972.63 | 119.72 | 131.5 | 144.6 | 159.58 | 174.45 | Upgrade
|
Total Debt | 25.46 | 238.51 | 237.62 | 235.35 | 233.11 | 226.33 | Upgrade
|
Net Cash (Debt) | -10.65 | -238.47 | -237.59 | -235.32 | -233.06 | -226.27 | Upgrade
|
Net Cash Per Share | -0.35 | -19.67 | -19.60 | -19.41 | -19.22 | -18.66 | Upgrade
|
Filing Date Shares Outstanding | 93.04 | 12.12 | 12.12 | 12.12 | 12.12 | 12.12 | Upgrade
|
Total Common Shares Outstanding | 93.04 | 12.12 | 12.12 | 12.12 | 12.12 | 12.12 | Upgrade
|
Working Capital | 218.77 | -240.37 | -238.37 | -236.24 | -233.29 | -231.18 | Upgrade
|
Book Value Per Share | 9.72 | -11.04 | -10.11 | -9.10 | -7.92 | -6.76 | Upgrade
|
Tangible Book Value | 866.59 | -133.8 | -122.62 | -110.29 | -96 | -81.95 | Upgrade
|
Tangible Book Value Per Share | 9.31 | -11.04 | -10.11 | -9.10 | -7.92 | -6.76 | Upgrade
|
Land | - | 13.55 | 13.55 | 13.55 | 13.55 | 13.55 | Upgrade
|
Buildings | - | 174.88 | 174.88 | 174.88 | 174.88 | 161.05 | Upgrade
|
Machinery | - | 108.93 | 108.93 | 108.93 | 108.93 | 125.4 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.